I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4% Market Closed
Market Cap: 17.7m PLN
Have any thoughts about
Inno-Gene SA?
Write Note

Inno-Gene SA
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inno-Gene SA
Total Liabilities & Equity Peer Comparison

Comparables:
M
MDB
R
RVU
S
SLV

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
I
Inno-Gene SA
WSE:IGN
Total Liabilities & Equity
zł5.5m
CAGR 3-Years
-34%
CAGR 5-Years
-22%
CAGR 10-Years
-8%
M
Medicofarma Biotech SA
WSE:MDB
Total Liabilities & Equity
zł16.4m
CAGR 3-Years
245%
CAGR 5-Years
58%
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Total Liabilities & Equity
zł406.6m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
33%
S
Selvita SA
WSE:SLV
Total Liabilities & Equity
zł642.8m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Inno-Gene SA's Total Liabilities & Equity?
Total Liabilities & Equity
5.5m PLN

Based on the financial report for Jun 30, 2024, Inno-Gene SA's Total Liabilities & Equity amounts to 5.5m PLN.

What is Inno-Gene SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
-8%

Over the last year, the Total Liabilities & Equity growth was -41%. The average annual Total Liabilities & Equity growth rates for Inno-Gene SA have been -34% over the past three years , -22% over the past five years , and -8% over the past ten years .

Back to Top